Page last updated: 2024-08-26

cyanopindolol and Autoimmune Disease

cyanopindolol has been researched along with Autoimmune Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anlar, B; Arnason, BG; Karaszewski, JW; Kim, WC; Reder, AT	1

Other Studies

1 other study(ies) available for cyanopindolol and Autoimmune Disease

Article	Year
Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell. Annals of neurology, 1991, Volume: 30, Issue:1 Topics: Adult; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Autoimmune Diseases; CD28 Antigens; CD8 Antigens; Cells, Cultured; Humans; Interleukin-2; Lymphocyte Activation; Middle Aged; Models, Biological; Multiple Sclerosis; Neurons, Afferent; Pindolol; Receptors, Adrenergic, beta; Recombinant Proteins; T-Lymphocyte Subsets; Up-Regulation	1991

Article

Year

Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell.

Annals of neurology, 1991, Volume: 30, Issue:1

Topics: Adult; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Autoimmune Diseases; CD28 Antigens; CD8 Antigens; Cells, Cultured; Humans; Interleukin-2; Lymphocyte Activation; Middle Aged; Models, Biological; Multiple Sclerosis; Neurons, Afferent; Pindolol; Receptors, Adrenergic, beta; Recombinant Proteins; T-Lymphocyte Subsets; Up-Regulation

1991